Introduction: Percutaneous transluminal coronary angioplasty (PTCA) is an effective method for revascularizing of stenotic coronary vessels. Lack of response to this treatment, either in symptomatic or asymptomatic patients, is usually due to incomplete revascularization, restenosis, and/or irreversibility of myocardial perfusion. Introduction of a noninvasive method with high predictive value ...

KURALAY, F., ALTEKIN, E., YAZLAR, A.S., ONVURAL, B. and GOLDELI, O. Suppression of Angioplasty-Related Inflammation by Pre-Procedural Treatment with Trimetazidine. Tohoku J. Exp. Med., 2006, 208 (3), 203-212 ── Percutaneous transluminal coronary angioplasty (PTCA) has been recognized as a reliable treatment procedure for acute reversible ischemia and reperfusion. Ischemic reperfusion cycle in P...

background: angioplasty is one of the most common methods for treating coronary artery diseases. however, a large number of those undergoing this treatment face psychological problems that negatively affect the quality of their life and recovery. we aimed to determine the effects of discharge planning on stress, anxiety, and depression in patients undergone percutaneous transluminal coronary an...

Regional coronary blood flow and myocardial metabolism were evaluated in a patient who underwent percutaneous transluminal coronary angioplasty (PTCA). Angioplasty increased coronary luminal diameter and reduced trans-stenotic gradient. Before PTCA, angina pectoris developed during sustained rapid atrial pacing and was associated with abnormal lactate metabolism and a mild increase in coronary ...

METHODS We prospectively evaluated the outcomes of 2,000 patients undergoing percutaneous transluminal coronary angioplasty (PTCA). According to a randomized, double-blind protocol, they received either iomeprol (nonionic; n 5 1,001) or ioxaglate (ionic; n 5 999). Intracoronary thrombus before PTCA was found more often in the iomeprol group (4.2% vs 2.7%, p 5 0.04). No other significant differe...

experimental and clinical studies have shown that intracoronary transplantation of autologous bone marrow mesenchymal stem cells (bmscs) has resulted in regenerated infarcted myocardium and improved left ventricular (lv) function.the aim of this pilot study was to assess the benefical effectsof intracoronary transplantation of bmsc in patients with oldmyocardial infarction (omi). autologous bms...

Patients who undergo percutaneous transluminal coronary angioplasty (PTCA) for coronary artery disease are at risk for recurrence at the site of the procedure. Placement of stents as an adjunct to PTCA is one strategy to reduce recurrence. The use of various techniques to apply intracoronary radiation through local application of catheters or placement of radioactive stents (also known as intra...

Reperfusion arrhythmias may be a cause of sudden death in acute myocardial infarction. A patient underwent successful coronary artery recanalisation by primary percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction. In this patient an idioventricular rhythm with a severe haemodynamic effect developed within one minute of deflation of the PTCA balloon. Sinus rhythm...

Percutaneous transluminal coronary angioplasty (PTCA) is a nonoperative mechanical dilatation of atherosclerotic coronary artery stenosis by a balloon-tipped dilating catheter system. This method can effectively reduce highly stenotic coronary lesions and provide early recovery of ischemic but viable myocardium. The technique of transluminal angioplasty was originally devised by Dotter and Judk...

Over the last two decades, a better understanding of the blood coagulation and platelet function, the introduction of effective pharmacological agents, increased use of coronary angiography, the development of advanced percutaneous techniques such as, percutaneous transluminal coronary angioplasty (PTCA), and coronary stenting have made a dramatic change in the acute management of myocardial in...